Hong Kong sees first chikungunya case from China outbreak
The patient is a 12-year-old boy who developed fever, rash and joint pain after traveling to Foshan in Guangdong Province in July, according to the city's public health agency. Hong Kong's health authorities believe the boy was infected there, and is now being treated in a mosquito-free environment with his household under medical surveillance.
The imported case is the city's first chikungunya infection since 2019. Foshan, a city just 90 minutes away by high-speed train, has seen over 6,500 people affected in the past few weeks. The outbreak has prompted another Chinese city to set up curbs reminiscent of the stringent approach from the pandemic era.
Fuzhou city in Fujian province started requiring travelers from Foshan to undergo a 14-day at-home quarantine. Macao, which last month reported an imported case involving a person who had traveled to Foshan, recorded a locally transmitted case last Friday - stoking concerns of regional transmission.
Hong Kong's Food and Environmental Hygiene Department undertook targeTted mosquito control operations at the patient's residence, including fogging, removing stagnant water and distributing publicity leaflets to boost awareness.
Although the virus doesn't spread from people to people, the disease can still spread if the infected person is bitten by mosquitoes, and if they in turn bite more people.
Hong Kong's strict response to Covid-19 is still fresh in people's minds. The city shut itself to the world for three years since Covid began in 2020, adopting stringent pandemic rules including travel restrictions, a mask mandate and quarantine camps.
Hundreds of thousands of people - including travelLers and infected residents - were sent to isolate in government-run centers such as Penny's Bay, where they had to endure spartan living conditions and attempts to escape could result in jail time. - Bloomberg
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 hours ago
- The Star
Romania reports 1,703 new COVID-19 cases, 7 deaths in July
BUCHAREST, Aug. 4 (Xinhua) -- Romania recorded 1,703 new cases of COVID-19 in July 2025, marking a 232 percent increase compared to the previous month, according to data released on Monday by the National Institute of Public Health (INSP). Of the total cases, 442 were reinfections, occurring more than 90 days after the initial diagnosis. The INSP also reported seven COVID-19-related deaths in July, involving five men and two women. Four of the individuals were aged 70 to 79, and three were over 80. All had underlying health conditions. Testing activity increased last month, with 860 RT-PCR tests and 14,750 rapid antigen tests performed, up 25.5 percent from June. The overall positivity rate rose to 10.9 percent, an increase of 6.8 percentage points. As of July 31, Romania had recorded 3,586,193 confirmed COVID-19 cases and 69,266 related deaths since the start of the pandemic.
New Straits Times
11 hours ago
- New Straits Times
Nada: 50,000 undergoing rehab at home, 5,100 in Puspen centres
KOTA BARU: More than 50,000 people undergoing rehabilitation with the National Anti-Drug Agency (Nada) are currently receiving scheduled treatment while living with their families. Nada director-general Datuk Ruslin Jusoh said another 5,100 clients are receiving treatment at 28 Narcotics Addiction Rehabilitation Centres (Puspen) across the country. "There are currently 28 Puspen operating nationwide, housing over 5,000 clients undergoing rehabilitation. "Two other centres are not in operation at the moment as they are undergoing renovations," he told reporters after attending the state-level Kelantan Drug Eradication Action Council meeting here today. Ruslin said 98.2 per cent of Puspen trainees are Malays, while the rest are Chinese, Indian, and other ethnic groups. He added that 3.2 per cent of the clients are women, with the remainder being men. In Kelantan, he said that there are three rehabilitation centres located in Bachok, Jeli, and Kota Baru, housing nearly 500 trainees. Ruslin said Nada continues to encourage individuals struggling with drug addiction to seek treatment voluntarily. "Early treatment can lead to early recovery. "Even at the federal level, Youth and Sports Minister Hannah Yeoh is spearheading campaigns to encourage young people to come forward for treatment voluntarily," he said. He acknowledged that some drug users may be reluctant to seek help due to misinformation. "Some fear treatment because they've heard it takes up to two years, but that's not true. "If a person recovers quickly, we can release them earlier.
Focus Malaysia
12 hours ago
- Focus Malaysia
Medical device sector thrives with trade surplus, growing foreign investment
MALAYSIA has a strong exporting power for medical devices. Unlike pharmaceuticals, Malaysia is largely a net exporter of medical devices. These are mainly consumables, diagnostics equipment and patient aids. Imports, meanwhile, shown a steady growth, a signal that Malaysia's healthcare demand for advanced medical technologies and equipment continue to grow. Malaysia consistently maintains a significant trade surplus in medical devices, highlighting the medical device sector as a key contributor to Malaysia's overall trade balance. While gloves constituted a large portion of the total medical device exports, non-glove exports overtook the total export for 2022 onwards. This shift is crucial as it indicates that Malaysia's efforts to diversify its medical device manufacturing base beyond gloves are bearing fruit. The significant growth in non-glove exports means the industry is becoming more resilient and less dependent on a single product category. This aligns with national goals of strengthening innovation capacity and moving up the value chain. As of quarter one of 2025, the total investment value in medical devices reached RM26.3 mil, spread across about 180 projects. Foreign investments had a slight upper hand in the medical devices' investment landscape, notably during post-Covid. This may suggest that, as global supply chains had normalized, foreign companies re-engaged with investment plans in Malaysia. The swings between DDI and FDI dominance also reflects specific government incentives in healthcare investments, promising global economic conditions for the subsector, and strategic shifts by both local and international players. On average, FDI dominated at 52.2% of the total investments. AI-based equipment and devices are expected to see a surge in demand, with market size projected to grow up to USD220 mil by 2030, at a very high five year compounded annual growth rate of 45.4%. The Malaysian Investment Development Authority (MIDA) had taken significant steps to include AI technology under its medical devices' regulations. The AI must be a medical device that uses machine learning (ML), in part or in whole, to achieve its intended medical purpose. The AI is expected to be under the jurisdiction of Section 2 of the Medical Device Act 2012 (Act 737). We believe this update to the regulatory framework is timely, aligning with the government's National Health Missions, Healthcare White Paper and NIMP 2030, as well the rapid growth in AI utilization in everyday life. Other drivers include: (i) Increasing healthcare data volume. (ii) Shortage of skilled healthcare professionals. (iii) Growing demand for cost reduction and operational efficiencies. (iv) Increased focus on personalized and preventive healthcare. While traditional clinical data remains paramount, there is a clear and accelerating trend in integration between data and technology, aiming towards incorporating real-world data from remote care, advanced 'omics' technologies for personalized insights, and external factors that shape an individual's health. This multi-faceted approach to data collection and analysis is crucial for developing more proactive, preventive, and personalized model. The ability to collect, integrate, and analyse these diverse data streams is paving the way for precision health, predictive analytics and more. However, the trends clearly indicate a future where digital data will be the bedrock of a more intelligent, efficient, and patient-centred healthcare system. —Aug 4, 2025 Main image: Stanton Chase
